April 15, 2017
India
Bedaquiline may be the answer to several drug-resistant patients in India, but the government is extra cautious about the rollout. The drug has been approved for only 600 patients for a six-month regime. Shahida is one among over 200 patients selected so far including 68 in Mumbai.